Publications by authors named "J F Gerstenmaier"
This is the first case report of 43-year-old lady with a myxoid hepatic adenoma which demonstrated significant contrast uptake during hepatobiliary phase imaging. This highlights the potential for a missed diagnosis and likely subsequent malignant transformation in a young patient in whom it was initially presumed to be focal nodular hyperplasia with no further surveillance.
View Article and Find Full Text PDFArticle Synopsis
- Pancreatic ductal adenocarcinoma (PDAC) is a serious cancer where accurately assessing resectability through CT scans is essential for determining the best treatment options for patients.
- In a study involving 96 clinicians, it was found that there was significant variability in how different surgeons and radiologists agreed on the resectability of pancreatic tumors based on CT scans.
- The results highlighted a fair overall agreement score of 0.32, with radiologists demonstrating better consistency than surgeons, indicating a need for more standardized assessment processes and central reviews in future treatments and studies.
Introduction: Acute gastrointestinal bleeding (GIB) is associated with morbidity and mortality. There can be a low threshold for practitioners to assess for active GIB and computed tomography angiography (CTA) examinations are performed frequently, even for stable patients and those who are therapeutically anticoagulated. We aimed to assess the predictive value of CTA for acute GIB and the influence of CTA on treatment.
View Article and Find Full Text PDFWhile dysplastic liver nodules in cirrhosis are pre-malignant, little is known about the predictors of hepatocarcinogenesis of these lesions. This was a retrospective observational study of subjects with cirrhosis who had at least one hypervascular, non-malignant intrahepatic nodule on imaging while undergoing outpatient management by a tertiary hepatology referral centre between Jan 2009 and Jan 2019. Clinical and biochemical parameters were collected.
View Article and Find Full Text PDFArticle Synopsis
- Higher levels of anti-TNF drugs (infliximab and adalimumab) are linked to better clinical healing of Crohn's perianal fistulas and improved radiologic outcomes.
- A study analyzed 193 patients with perianal fistulising Crohn's disease, comparing drug levels and MRI results to determine healing status and radiologic remission.
- Results showed that patients with higher drug levels had significantly better radiologic healing and remission scores, indicating a positive correlation between drug concentration and reduced disease activity.